Literature DB >> 23148142

Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders.

Demian Obregon1, Ellisa Carla Parker-Athill, Jun Tan, Tanya Murphy.   

Abstract

Antimicrobial compounds and psychotropic medications often share overlapping mechanisms of actions and pharmacological effects. The immune system appears to be an important site of interaction as several antimicrobials display neurological and, at times, direct psychotropic effects, while psychotropics have shown significant immunomodulatory properties. The isoniazid class of antibiotics for example has been shown to possess monoamine oxidase activity, while selective serotonin reuptake inhibitors have shown significant effects on leukocyte populations. As the importance of the immune system's role in CNS homeostasis and disease continues to move to the forefront of neuropsychiatric research, these shared pharmacological effects may provide an important insight, elucidating the complexities in neuroimmune pathophysiology and guiding the development of potential treatments.

Entities:  

Year:  2012        PMID: 23148142      PMCID: PMC3494283          DOI: 10.2217/npy.12.41

Source DB:  PubMed          Journal:  Neuropsychiatry (London)        ISSN: 1758-2008


  106 in total

1.  [Largactil in the treatment of tuberculosis].

Authors:  H GEIGER; B A FINKEISTEIN
Journal:  Schweiz Med Wochenschr       Date:  1954-09-11

2.  Studies on immunomodulatory properties of isoniazid. III. Effect of isoniazid on proliferation of interleukin-dependent and interleukin-independent cell line.

Authors:  E J Kucharz; S J Sierakowski
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1990

3.  Antibiotic therapy may improve idiopathic restless legs syndrome: prospective, open-label pilot study of rifaximin, a nonsystemic antibiotic.

Authors:  Leonard B Weinstock
Journal:  Sleep Med       Date:  2009-12-29       Impact factor: 3.492

4.  Antibodies against cerebral M1 cholinergic muscarinic receptor from schizophrenic patients: molecular interaction.

Authors:  Tania Borda; Ricardo Perez Rivera; Lilian Joensen; Ricardo M Gomez; Leonor Sterin-Borda
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

5.  Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study.

Authors:  Yared Tedla; Teshome Shibre; Oumer Ali; Geletta Tadele; Yimtubezinash Woldeamanuel; Daniel Asrat; Abraham Aseffa; Wude Mihret; Markos Abebe; Atalaye Alem; Girmay Medhin; Abebe Habte
Journal:  Ethiop Med J       Date:  2011-07

6.  Antidepressant-like effects of ceftriaxone in male C57BL/6J mice.

Authors:  Yann S Mineur; Marina R Picciotto; Gerard Sanacora
Journal:  Biol Psychiatry       Date:  2006-07-24       Impact factor: 13.382

Review 7.  Viruses, schizophrenia, and bipolar disorder.

Authors:  R H Yolken; E F Torrey
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

8.  A controlled trial of methylene blue in severe depressive illness.

Authors:  G J Naylor; A H Smith; P Connelly
Journal:  Biol Psychiatry       Date:  1987-05       Impact factor: 13.382

9.  Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

Authors:  M Maes; E Bosmans; R De Jongh; G Kenis; E Vandoolaeghe; H Neels
Journal:  Cytokine       Date:  1997-11       Impact factor: 3.861

10.  Clavulanic acid: a competitive inhibitor of beta-lactamases with novel anxiolytic-like activity and minimal side effects.

Authors:  Deog J Kim; Jean A King; Lisa Zuccarelli; Craig F Ferris; Gary A Koppel; Charles T Snowdon; Chang H Ahn
Journal:  Pharmacol Biochem Behav       Date:  2009-04-24       Impact factor: 3.533

View more
  8 in total

1.  Cytokine correlations in youth with tic disorders.

Authors:  E Carla Parker-Athill; Jared Ehrhart; Jun Tan; Tanya K Murphy
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-02-06       Impact factor: 2.576

2.  In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions.

Authors:  S Flanagan; K Bartizal; S L Minassian; E Fang; P Prokocimer
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

3.  Inflammation and Depression: the Neuroimmune Connection.

Authors:  Marisa Toups
Journal:  Curr Treat Options Psychiatry       Date:  2018-10-22

4.  Treatment of Pediatric Acute-Onset Neuropsychiatric Disorder in a Large Survey Population.

Authors:  Denise Calaprice; Janice Tona; Tanya K Murphy
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-08-23       Impact factor: 2.576

Review 5.  Are antibacterial effects of non-antibiotic drugs random or purposeful because of a common evolutionary origin of bacterial and mammalian targets?

Authors:  Axel Dalhoff
Journal:  Infection       Date:  2020-12-15       Impact factor: 3.553

Review 6.  Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks?

Authors:  Axel Dalhoff
Journal:  Infection       Date:  2020-12-23       Impact factor: 7.455

Review 7.  Neuropsychiatric Lyme Borreliosis: An Overview with a Focus on a Specialty Psychiatrist's Clinical Practice.

Authors:  Robert C Bransfield
Journal:  Healthcare (Basel)       Date:  2018-08-25

8.  Transcriptome-wide association study of treatment-resistant depression and depression subtypes for drug repurposing.

Authors:  Chiara Fabbri; Oliver Pain; Saskia P Hagenaars; Cathryn M Lewis; Alessandro Serretti
Journal:  Neuropsychopharmacology       Date:  2021-06-22       Impact factor: 7.853

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.